BlackRock Japan’s PDS Biotechnology PDSB Stock Holding History

BlackRock Japan’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-38	Closed	-$8K	–	1394
2016 Q2	$8K	Buy	+38	New	+$6.72K	﹤0.01%	1295

Other funds holding PDSB

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock Japan's PDSB Position: Q3 2016 in Review

BlackRock Japan sold out of PDS Biotechnology (PDSB) in Q3 2016, closing a stake of 38 shares — an estimated $8K sold.

BlackRock Japan first reported a position in PDSB in Q2 2016 and held it in 1 quarter. The position peaked at $8K in Q2 2016. 51 funds tracked by Wall St. Rank hold PDSB as of Q3 2016.

BlackRock Japan reported no remaining PDS Biotechnology position as of Q3 2016 after selling out during the quarter.
BlackRock Japan sold 38 PDS Biotechnology shares in Q3 2016, an estimated $8K.
BlackRock Japan first reported a position in PDS Biotechnology in Q2 2016 and held it in 1 quarter.
BlackRock Japan's PDS Biotechnology position peaked at $8K in Q2 2016.
51 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.